Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
GZPHF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $3,804 | $25,976 | $27,966 | $34,175 |
| - Cash | $1,925 | $11,827 | $14,511 | $18,273 |
| + Debt | $2,919 | $13,265 | $11,546 | $12,374 |
| Enterprise Value | $4,799 | $27,414 | $25,001 | $28,276 |
| Revenue | $2,775 | $19,361 | $22,473 | $15,933 |
| % Growth | -85.7% | -13.8% | 41.1% | – |
| Gross Profit | $447 | $3,053 | $4,610 | $2,064 |
| % Margin | 16.1% | 15.8% | 20.5% | 13% |
| EBITDA | $168 | $962 | $2,333 | -$298 |
| % Margin | 6% | 5% | 10.4% | -1.9% |
| Net Income | $111 | $695 | $1,821 | -$323 |
| % Margin | 4% | 3.6% | 8.1% | -2% |
| EPS Diluted | 0.069 | 0.43 | 1.12 | -0.2 |
| % Growth | -84.1% | -61.6% | 660% | – |
| Operating Cash Flow | $237 | $500 | -$3,897 | $0 |
| Capital Expenditures | -$59 | -$271 | -$226 | -$316 |
| Free Cash Flow | $179 | $229 | -$4,124 | $3,878 |